Li‐Fraumeni versus Pseudo‐Li‐Fraumeni Syndrome: Key Insights for Interpreting Next‐Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes

This brief communication describes the case of a patient with colorectal cancer with a TP53 germline mutation initially considered somatic because no TP53 germline mutation was noted in the liquid biopsy (cell‐free DNA) next‐generation sequencing assay.

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Sorscher, Steven, Desnoyers, Rodwige, Ouyang, Karen, Ramkissoon, Shakti
Materialtyp: Artigo
Språk:Inglês
Publicerad: AlphaMed Press 2017
Ämnen:
Brief Communications
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599202/
https://ncbi.nlm.nih.gov/pubmed/28592622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0016
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk